141 related articles for article (PubMed ID: 31483053)
21. Immunohistochemical expression of GPR30 in breast carcinoma of Egyptian patients: an association with immunohistochemical subtypes.
Aiad HA; Wahed MM; Asaad NY; El-Tahmody M; Elhosary E
APMIS; 2014 Oct; 122(10):976-84. PubMed ID: 24628533
[TBL] [Abstract][Full Text] [Related]
22. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF.
Filardo EJ; Quinn JA; Bland KI; Frackelton AR
Mol Endocrinol; 2000 Oct; 14(10):1649-60. PubMed ID: 11043579
[TBL] [Abstract][Full Text] [Related]
23. The novel estrogen receptor G-protein-coupled receptor 30 is expressed in human bone.
Heino TJ; Chagin AS; Sävendahl L
J Endocrinol; 2008 May; 197(2):R1-6. PubMed ID: 18434348
[TBL] [Abstract][Full Text] [Related]
24. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.
Skrzypczak M; Schüler S; Lattrich C; Ignatov A; Ortmann O; Treeck O
Steroids; 2013 Nov; 78(11):1087-91. PubMed ID: 23921077
[TBL] [Abstract][Full Text] [Related]
25. 17β-Estradiol on the Expression of G-Protein Coupled Estrogen Receptor (GPER/GPR30) Mitophagy, and the PI3K/Akt Signaling Pathway in ATDC5 Chondrocytes In Vitro.
Fan DX; Yang XH; Li YN; Guo L
Med Sci Monit; 2018 Apr; 24():1936-1947. PubMed ID: 29608013
[TBL] [Abstract][Full Text] [Related]
26. G protein-coupled estrogen receptor 1 expression in human vocal fold.
Wu D; Jiang JJ; Fang R; Swinarski K; Cui X
Laryngoscope; 2013 Apr; 123(4):948-51. PubMed ID: 23494473
[TBL] [Abstract][Full Text] [Related]
27. Differential expression of various clones of estrogen receptor in cell block preparation of lung adenocarcinoma.
Hakima L; Schlesinger K; Sunkara J; Karabakhtsian RG
Diagn Cytopathol; 2018 May; 46(5):390-394. PubMed ID: 29465823
[TBL] [Abstract][Full Text] [Related]
28. Nestin: A biomarker of aggressive uterine cancers.
Hope ER; Mhawech-Fauceglia P; Pejovic T; Zahn CM; Wang G; Conrads TP; Larry Maxwell G; Hamilton CA; Darcy KM; Syed V
Gynecol Oncol; 2016 Mar; 140(3):503-11. PubMed ID: 26718725
[TBL] [Abstract][Full Text] [Related]
29. Expression of p21WAF1/CIP1 in adenocarcinoma of the uterine cervix: a possible immunohistochemical marker of a favorable prognosis.
Lu X; Toki T; Konishi I; Nikaido T; Fujii S
Cancer; 1998 Jun; 82(12):2409-17. PubMed ID: 9635534
[TBL] [Abstract][Full Text] [Related]
30. Significance of estrogen receptors and cathepsin D tissue detection in gastric adenocarcinoma.
Theodoropoulos GE; Lazaris AC; Panoussopoulos D; Davaris P; Golematis BC
J Surg Oncol; 1995 Mar; 58(3):176-83. PubMed ID: 7898114
[TBL] [Abstract][Full Text] [Related]
31. Unusual endocervical adenocarcinomas: an immunohistochemical analysis with molecular detection of human papillomavirus.
Park KJ; Kiyokawa T; Soslow RA; Lamb CA; Oliva E; Zivanovic O; Juretzka MM; Pirog EC
Am J Surg Pathol; 2011 May; 35(5):633-46. PubMed ID: 21490443
[TBL] [Abstract][Full Text] [Related]
32. G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer.
Ignatov A; Ignatov T; Weissenborn C; Eggemann H; Bischoff J; Semczuk A; Roessner A; Costa SD; Kalinski T
Breast Cancer Res Treat; 2011 Jul; 128(2):457-66. PubMed ID: 21607586
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of the co-expression of EGFR and HER2 in adenocarcinoma of the uterine cervix.
Ueda A; Takasawa A; Akimoto T; Takasawa K; Aoyama T; Ino Y; Nojima M; Ono Y; Murata M; Osanai M; Hasegawa T; Saito T; Sawada N
PLoS One; 2017; 12(8):e0184123. PubMed ID: 28859123
[TBL] [Abstract][Full Text] [Related]
34. G Protein-Coupled Receptor 30 (GPR30) Expression Pattern in Inflammatory Bowel Disease Patients Suggests its Key Role in the Inflammatory Process. A Preliminary Study.
Włodarczyk M; Sobolewska-Włodarczyk A; Cygankiewicz AI; Jacenik D; Piechota-Polańczyk A; Stec-Michalska K; Krajewska WM; Fichna J; Wiśniewska-Jarosińska M
J Gastrointestin Liver Dis; 2017 Mar; 26(1):29-35. PubMed ID: 28338111
[TBL] [Abstract][Full Text] [Related]
35. Panel of Villin, Pro-Ex-C, Estrogen Receptor and Progesterone Receptor Expressions Could Help in Differentiation Between Endocervical and Endometrioid Adenocarcinoma.
Elfeky M; Harb O; Gertallah L
Turk Patoloji Derg; 2017; 1(1):29-40. PubMed ID: 28832070
[TBL] [Abstract][Full Text] [Related]
36. Adenocarcinoma of the cervix. Expression and clinical significance of estrogen and progesterone receptors.
Fujiwara H; Tortolero-Luna G; Mitchell MF; Koulos JP; Wright TC
Cancer; 1997 Feb; 79(3):505-12. PubMed ID: 9028361
[TBL] [Abstract][Full Text] [Related]
37. Cytoplasmic FOXP1 expression is correlated with ER and calpain II expression and predicts a poor outcome in breast cancer.
Yu BH; Li BZ; Zhou XY; Shi DR; Yang WT
Diagn Pathol; 2018 May; 13(1):36. PubMed ID: 29848352
[TBL] [Abstract][Full Text] [Related]
38. The correlation between GPR30 and clinicopathologic variables in breast carcinomas.
Tu G; Hu D; Yang G; Yu T
Technol Cancer Res Treat; 2009 Jun; 8(3):231-4. PubMed ID: 19445541
[TBL] [Abstract][Full Text] [Related]
39. Intestinal-type cervical adenocarcinoma in situ and adenocarcinoma exhibit a partial enteric immunophenotype with consistent expression of CDX2.
McCluggage WG; Shah R; Connolly LE; McBride HA
Int J Gynecol Pathol; 2008 Jan; 27(1):92-100. PubMed ID: 18156982
[TBL] [Abstract][Full Text] [Related]
40. GPR30 estrogen receptor expression in the growth plate declines as puberty progresses.
Chagin AS; Sävendahl L
J Clin Endocrinol Metab; 2007 Dec; 92(12):4873-7. PubMed ID: 17878253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
